Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/30/20 16:34 | 11/25/20 | MRVI | Health | Drug | Pharmaceutical Preparations | Hull Carl | CA | DO | CEO | P | 943 | 26.94 | 0 | 35 | New | 35 | I | ||||||||||||||
11/25/20 19:58 | 11/24/20 | MRVI | Health | Drug | Pharmaceutical Preparations | Gray Susannah | CA | D | P | 540 | 27.00 | 0 | 20 | 169 | 32 | D | |||||||||||||||
11/25/20 19:54 | 11/24/20 | MRVI | Health | Drug | Pharmaceutical Preparations | Sellers Lisa | CA | O | See Rema | P | 510 | 27.00 | 0 | 19 | New | 19 | D | ||||||||||||||
11/25/20 19:54 | 11/24/20 | MRVI | Health | Drug | Pharmaceutical Preparations | Hance Robert B | CA | D | P | 270 | 27.00 | 0 | 10 | 84 | 22 | D | |||||||||||||||
11/25/20 19:53 | 11/24/20 | MRVI | Health | Drug | Pharmaceutical Preparations | Prahalad Murali | CA | D | P | 486 | 27.00 | 0 | 18 | 152 | 30 | D | |||||||||||||||
11/25/20 19:52 | 11/24/20 | MRVI | Health | Drug | Pharmaceutical Preparations | Lucier Gregory T | CA | D | P | 405 | 27.00 | 0 | 15 | 127 | 27 | D | |||||||||||||||
11/25/20 19:52 | 11/24/20 | MRVI | Health | Drug | Pharmaceutical Preparations | Hopfield Jessica | CA | D | P | 1,350 | 27.00 | 0 | 50 | 422 | 62 | D | |||||||||||||||
11/25/20 19:52 | 11/24/20 | MRVI | Health | Drug | Pharmaceutical Preparations | Oreshack Kurt | CA | O | GC | P | 203 | 27.00 | 0 | 8 | New | 8 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |